These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 19690302)
21. The Relationship Between Industry and Pain Societies, Part 1: Demystification and Legitimization of Continuing Medical Education. Darnall BD; Schatman ME Pain Med; 2015 Jul; 16(7):1251. PubMed ID: 26138746 [No Abstract] [Full Text] [Related]
22. Industry Funded Continuing Medical Education: The Potential for Bias. Stanton M Pain Med; 2015 Jul; 16(7):1253-4. PubMed ID: 26132977 [No Abstract] [Full Text] [Related]
23. Industry-Funded Continuing Medical Education: The Potential for Bias. Schofferman J Pain Med; 2015 Jul; 16(7):1252-3. PubMed ID: 26138829 [No Abstract] [Full Text] [Related]
24. Financial conflicts of interest and the NIH. Steinbrook R N Engl J Med; 2004 Jan; 350(4):327-30. PubMed ID: 14736923 [No Abstract] [Full Text] [Related]
25. Unease on industry's role in hypertension debate. Saul S N Y Times Web; 2006 May; ():A1, C9. PubMed ID: 16752458 [No Abstract] [Full Text] [Related]
26. Rebuttal: Is CME a drug-promotion tool?: NO. Marlow B Can Fam Physician; 2007 Nov; 53(11):1877, 1878-9. PubMed ID: 18000248 [No Abstract] [Full Text] [Related]
27. Fighting graft--it's academic. Medical centers must embrace conflict rules: critics. Romano M Mod Healthc; 2006 Jan; 36(5):8-10. PubMed ID: 16479773 [No Abstract] [Full Text] [Related]
28. The role of industry interactions with the American College of Gastroenterology. ACG Professional Affairs Committee Am J Gastroenterol; 2012 Jun; 107(6):800-3. PubMed ID: 22664840 [No Abstract] [Full Text] [Related]
29. Rebuttal: Is CME a drug-promotion tool?: YES. Steinman MA; Baron RB Can Fam Physician; 2007 Nov; 53(11):1877, 1878-9. PubMed ID: 18000249 [No Abstract] [Full Text] [Related]
30. [Physicians and the drug industry. "To be like that, you'd better be married."]. Peiró S Rev Calid Asist; 2009 Apr; 24(2):47-50. PubMed ID: 19426926 [No Abstract] [Full Text] [Related]
31. Why the data diverge on the dangers of Vioxx: even in medical journals, statistics can be subject to broad interpretation. Pollack A; Abelson R N Y Times Web; 2006 May; ():C1, C5. PubMed ID: 16752456 [No Abstract] [Full Text] [Related]
32. [Scientific societies and their economic relationship with the companies. Situation in Spain]. Ruano-Ravina A Med Clin (Barc); 2012 May; 138(14):614-6. PubMed ID: 22440141 [No Abstract] [Full Text] [Related]
33. Conflicts of Interest and Professional Medical Associations: Progress and Remaining Challenges. Nissen SE JAMA; 2017 May; 317(17):1737-1738. PubMed ID: 28464156 [No Abstract] [Full Text] [Related]
34. The ethics of engagement with the pharmaceutical industry. Almirall N Mich Med; 2006; 105(1):10-2. PubMed ID: 16555742 [No Abstract] [Full Text] [Related]
35. Health professional associations and industry funding. Costello A; Branca F; Rollins N; Stahlhofer M; Grummer-Strawn L Lancet; 2017 Feb; 389(10069):597-598. PubMed ID: 28195050 [No Abstract] [Full Text] [Related]
36. Industry support of medical education. Relman AS JAMA; 2008 Sep; 300(9):1071-3. PubMed ID: 18768419 [No Abstract] [Full Text] [Related]
38. Physician education and the pharmaceutical industry. Johnson RG Chest; 2001 Apr; 119(4):995-6. PubMed ID: 11296157 [No Abstract] [Full Text] [Related]
39. Society of American Gastrointestinal and Endoscopic Surgeons(SAGES)statement on the relationship between professional medical associations and industry. Society of American Gastrointestinal and Endoscopic Surgeons Surg Endosc; 2010 Apr; 24(4):742-4. PubMed ID: 20039070 [TBL] [Abstract][Full Text] [Related]
40. Considerations in the relationship between the American College of Chest Physicians and industry. Lever A Chest; 2001 Apr; 119(4):1257-9. PubMed ID: 11296196 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]